Home » Archive by Category


San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Mapp named a Fierce 15 biotech

September 22, 2014 – 9:49 am | Edit Post

Mapp Biopharmaceutical makes top biotech list.

Good Morning! It’s time to take the Celsius Quiz.

September 22, 2014 – 8:33 am | Edit Post

Celsius Quiz on National Cholesterol Awareness Month

Unique pathway that homes cancer drugs to tumors is like no other

September 22, 2014 – 8:11 am | Edit Post

A new study published in Nature Communications identifies the unique pathway that enhances the delivery of anti-cancer drugs to tumors.

Avalon-GSK Collaboration Generates Two More Startups in San Diego

September 22, 2014 – 6:33 am | Edit Post

San Diego’s Avalon Ventures is taking the wraps off two new startups today, with each one getting as much as $10 million in Series A financing through the partnership that Avalon established early…
[[Click headline to continue reading.]]

New Genomic Equipment at TSRI Enables Scientists to Analyze Single Cells

September 22, 2014 – 12:00 am | Edit Post

“It has added power to many of the technologies we already have on campus,” says Professor Luc Teyton.

Jack Johnson Honored as Outstanding Mentor

September 22, 2014 – 12:00 am | Edit Post

Professor Jack Johnson was nominated with 22 letters of support from current and former trainees.

TSRI Chemists Modify Antibiotic to Vanquish Resistant Bacteria

September 22, 2014 – 12:00 am | Edit Post

The Boger lab has made a powerful analog of vancomycin that is effective against MRSA and other disease-causing bacteria.

Toward a New Drug for Multiple Sclerosis

September 22, 2014 – 12:00 am | Edit Post

On the occasion of positive new data for RPC1063, Professor Hugh Rosen shares his perspective on the drug candidate, which was initially discovered, synthesized and developed at TSRI.

Mood switch found by UCSD scientists

September 19, 2014 – 6:37 pm | Edit Post

UCSD scientists found a twist in how bad news affects the brain, and depression therapy may benefit.

SGB Is Preparing for Commercial Roll Out of Jatropha

September 19, 2014 – 3:17 pm | Edit Post

SGB Inc., a local agricultural biotech company, has closed an $11 million Series C financing round to help drive the commercial roll out of its hybrid crops — a low-cost and sustainable plant-based option for fuel, energy-producing biomass and protein in animal feed.